Administration of study drug

DRUG3 trials

Conditions

Chronic constipation Chronic constipation,Gut microbiotaMorbid Obesityepithelial skin malignancies (e.g. cutaneous squamous cell carcinoma, extramammary Paget's disease)

Phase 2

Anti-PD-1 antibody therapy for epithelial skin malignancies: an investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial

Active, not recruitingJPRN-jRCT2031190048

Funakoshi Takeruepithelial skin malignancies (e.g. cutaneous squamous cell carcinoma, extramammary Paget's disease)

Start: 2019-09-02Target: 30Updated: 2026-06-29

Phase 4

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

CompletedNCT02320604

Radboud University Medical CenterMorbid Obesity

Start: 2018-03-22End: 2018-11-03Updated: 2020-10-19

Unknown Phase

Examination of the probiotics for chronic constipation symptoms (PCC Trial)

Active, not recruitingJPRN-jRCTs031210344

Asaoka DaisukeChronic constipation Chronic constipation,Gut microbiota

Start: 2021-09-24Target: 50Updated: 2026-06-29

Related Papers

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

BMC Cancer2026-03-04

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals